The Prostatype® Test System – a new gene test for prostate cancer patients
Our vision is that doctors and patients, confronted with diagnosed prostate cancer, have full confidence in their treatment decisions.
Chundsell Medicals’ mission is to make a difference in prostate cancer patients’ lives through the discovery and commercialization of transformative tests to guide treatment decisions. We can thereby increase quality of life and peace-of-mind for patients and simultaneously reduce health care costs. Chundsell Medicals will achieve this by making PrTS the global test system of choice for newly diagnosed prostate cancer patients.